BridgeBio Comes Back With Positive Phase III Results For Acoramidis In ATTR-CM

 
• By Alaric DeArment
BridgeBio announced data from its Phase III trial of acoramidis in ATTR-CM • Source: Shutterstock

More from Clinical Trials

More from R&D